Expanding the black box - Depression, antidepressants, and the risk of suicide

New England Journal of Medicine

Volumn 356, Issue 23, 2007, Pages 2343-2346

  Friedman, Richard A ^a   Leon, Andrew C ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b FDA's Psychopharmacologic Drugs Advisory Committee ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; PLACEBO;

CLINICAL TRIAL; DEPRESSION; DISEASE ASSOCIATION; FOOD AND DRUG ADMINISTRATION; HUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SHORT SURVEY; SUICIDE; THINKING;

EID: 34250002859     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp078015     Document Type: Article

References (5)

1. Hammad TA, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry 2006;63:332-9.
2. Harris G. Study finds less antidepressant use. New York Times. September 21, 2004:C1.
3. Gibbons RD, Hur K, Bhaumik DK, Mann JJ. The relationship between antidepressant prescription rates and rate of early adolescent suicide. Am J Psychiatry 2006;163:1898-904.
4. Leon AC, Marzuk PM, Tardiff K, Bucciarelli A, Markham Piper T, Galea S. Antidepressants and youth suicide in New York City, 1999-2002. J Am Acad Child Adolesc Psychiatry 2006;45:1054-8.
5. American Psychiatric Association practice guideline for the assessment and treatment of patients with suicidal behaviors. Am J Psychiatry 2003;160:Suppl:11.